financetom
Business
financetom
/
Business
/
Starbucks Faces Downside Earnings Risk Without Significant Sales Improvement, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Starbucks Faces Downside Earnings Risk Without Significant Sales Improvement, Oppenheimer Says
Jul 31, 2024 11:59 AM

02:34 PM EDT, 07/31/2024 (MT Newswires) -- Starbucks ( SBUX ) is still faced with downside risk to earnings after the coffee chain company maintained its full-year outlook, including EPS growth of flat to low-single-digits, Oppenheimer said Wednesday.

"Our updated analysis suggests risk remains to consensus EPS through 2025," Oppenheimer analysts Brian Bittner and Michael Tamas said. "We continue to see above-average downside earnings risk (vs. peers) without a significant acceleration in SSS or path for materially better margin performance into 2025."

The analysts said they are still on the hunt for signs that business trends have stabilized and earnings revisions have bottomed before reverting to a bullish stance. Oppenheimer reiterated its perform rating on the stock.

"A less cautious thesis requires an identifiable path for positive earnings revisions, but our analysis suggests Street's double-digit EPS growth estimate for fiscal '25 continues to hold above-average risk," they said.

Price: 79.31, Change: +3.37, Percent Change: +4.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Primaris REIT Details $69.6 Million Treasury and Secondary Unit Offering
Primaris REIT Details $69.6 Million Treasury and Secondary Unit Offering
Oct 2, 2024
04:33 PM EDT, 10/02/2024 (MT Newswires) -- Primaris Real Estate Investment Trust (PMZ-UN.TO) and Canada Pension Plan Investment Board (CPPIB) after trade Wednesday entered into an agreement with a syndicate of underwriters who will purchase, on a bought-deal basis, an aggregate of 4.47 million units of Primaris at a price of $15.55 each. The offering consists of a treasury offering...
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Oct 2, 2024
04:37 PM EDT, 10/02/2024 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Wednesday it is collaborating with AstraZeneca ( AZN ) in a clinical trial to evaluate a combination of casdatifan with volrustomig to treat patients with clear cell renal cell carcinoma. Casdatifan is Arcus's investigational and volrustomig is AstraZeneca's ( AZN ) investigational PD-1/CTLA-4 bispecific antibody. This is...
Levi Strauss Fiscal Q3 Adjusted Earnings, Net Revenue Rise
Levi Strauss Fiscal Q3 Adjusted Earnings, Net Revenue Rise
Oct 2, 2024
04:34 PM EDT, 10/02/2024 (MT Newswires) -- Levi Strauss (LEVI) reported fiscal Q3 adjusted earnings late Wednesday of $0.33 per diluted share, up from $0.28 a year earlier. Analysts polled by Capital IQ expected $0.31. Net revenue in the quarter ended Aug. 25 rose to $1.52 billion from $1.51 billion a year earlier. Analysts surveyed by Capital IQ expected $1.55...
Fidelity National Financial Acquires First Nationwide Title Agency
Fidelity National Financial Acquires First Nationwide Title Agency
Oct 2, 2024
04:33 PM EDT, 10/02/2024 (MT Newswires) -- Fidelity National Financial ( FNF ) said Wednesday it acquired commercial operations of First Nationwide Title Agency, which is a division of AMT Commercial Title Services and a subsidiary of AmTrust Financial Services. As part of the acquisition, FNTA's key commercial leadership team will join FNF, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved